-
Ruxolitinib (INCB018424) in Myeloproliferative Disorder Rese
2026-06-13
Ruxolitinib (INCB018424) empowers researchers to dissect JAK-STAT pathway inhibition in both hematologic malignancy and advanced tumor immunology. This guide translates recent high-dimensional immunoprofiling advances and evidence-based workflows into actionable lab protocols, with troubleshooting strategies for reproducible, publication-grade results.
-
Insulin-AMPK Control of Pink1 mRNA Localization in Neuronal
2026-06-12
The referenced study uncovers how insulin signaling regulates Pink1 mRNA localization at mitochondria in neurons via AMPK activity, directly impacting PINK1-dependent mitophagy. This mechanistic link provides new insight into the metabolic modulation of mitochondrial quality control and offers a conceptual framework for modeling neurodegenerative disease mechanisms in the laboratory.
-
Epacadostat (INCB024360): Reliable IDO1 Inhibition for Immun
2026-06-12
This article addresses core laboratory challenges in immuno-metabolic assays and cell-based immune modulation, demonstrating how Epacadostat (INCB024360), Orally active indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor (SKU B6036) provides reliable, reproducible solutions. Integrating evidence from protocol literature and product data, it guides researchers seeking robust IDO1 inhibition for assay sensitivity, workflow compatibility, and data interpretation.
-
Arachidonic Acid Supplementation Rapidly Enhances Humoral Im
2026-06-11
A recent study demonstrates that dietary supplementation with arachidonic acid, a polyunsaturated omega-6 fatty acid, markedly accelerates and amplifies the humoral immune response to rabies vaccination in both mice and humans. The findings uncover a lymph node-localized metabolic pathway, positioning arachidonic acid as a potential dietary adjuvant for rapid vaccine-induced protection.
-
Ruxolitinib (INCB018424): Translational Impact in Immune Mod
2026-06-11
Explore how Ruxolitinib (INCB018424) enables advanced immunomodulation in translational research, with new insights into assay design and immune landscape analysis. This cornerstone article dissects recent innovations and practical protocols for myeloproliferative disorder research.
-
ATM Inhibition and Fenofibrate Synergy in Ovarian Cancer Cel
2026-06-10
This study demonstrates that ATM inhibition synergizes with fenofibrate, a PPARα agonist, to induce senescence in high grade serous ovarian cancer (HGSOC) cell lines. The findings propose a metabolic vulnerability in HR-proficient HGSOC, offering a rationale for combinatorial strategies beyond DNA-damaging agents.
-
HBsAg-TBK1 Interaction Suppresses IFN-I and Induces Early Au
2026-06-10
This study uncovers a mechanism by which hepatitis B surface antigen (HBsAg) manipulates the host kinase TBK1 to suppress type I interferon (IFN-I) signaling and induce incomplete autophagy. The findings clarify how HBV evades innate immunity, highlighting the molecular crosstalk between antiviral signaling and autophagic pathways, with implications for persistent infection.
-
Simvastatin (Zocor) SKU A8522: Evidence-Driven Cell Assay So
2026-06-09
This article provides a scenario-driven, evidence-based exploration of Simvastatin (Zocor) (SKU A8522) for researchers conducting cell viability, proliferation, and cytotoxicity assays. Drawing on quantitative data, published protocols, and real-world lab challenges, we demonstrate how this APExBIO compound offers reliable, reproducible, and mechanistically sound solutions for studies in hyperlipidemia, hepatic cancer, and cardiovascular disease.
-
DiscoveryProbe Protease Inhibitor Library: Precision Tools f
2026-06-09
Explore how the DiscoveryProbe Protease Inhibitor Library advances precision protease inhibition for mechanistic research, assay optimization, and drug discovery. This article uniquely emphasizes assay design insights and practical application strategies.
-
DiscoveryProbe Protease Inhibitor Library: Applied HTS Workf
2026-06-08
The DiscoveryProbe Protease Inhibitor Library empowers researchers to dissect protease biology through automation-ready, high-throughput screening and advanced mechanistic studies. This guide details optimized experimental workflows, troubleshooting strategies, and actionable protocol parameters—highlighting how APExBIO's validated library sets a new benchmark for assay reliability in apoptosis, cancer, and infectious disease research.
-
Molecular Networks Governing Fruit Abscission in Actinidia a
2026-06-08
Yuan et al. (2025) dissect the transcriptional and hormonal mechanisms underlying physiological fruit abscission in Actinidia arguta using comparative transcriptomics and transient gene overexpression. Their work identifies key regulatory genes and hormone pathways, providing new targets for breeding strategies to mitigate yield loss in kiwiberry cultivars.
-
Standardized Whole-Blood Stimulation Unveils Metabolic Immun
2026-06-07
This study establishes a robust protocol for analyzing immune responses in human whole blood under metabolic modulation. By quantifying cytokine production following diverse metabolic pathway interventions, the protocol advances immunometabolic research and offers a powerful, reproducible platform for dissecting immune-metabolic crosstalk.
-
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe Use
2026-06-06
DiI (DiIC18(3)) provides robust plasma membrane labeling for cell biology and neuroscience workflows, including neuronal tracing and cell migration assays. It is not suitable for aqueous staining protocols or for labeling intracellular organelles, and requires careful protocol setup to ensure membrane-specific fluorescence.
-
Epacadostat (INCB024360): Redefining Metabolic Immune Modula
2026-06-05
Explore how Epacadostat (INCB024360) enables advanced metabolic immune modulation through precise IDO1 inhibition. This article uniquely bridges standardized immunometabolic protocols and practical assay innovation for immuno-oncology research.
-
Surfactant-Derived LNPs for Efficient mRNA Delivery to Macro
2026-06-05
The referenced study introduces a dual-component lipid nanoparticle (LNP) system employing surfactant-derived ionizable lipids for efficient messenger RNA (mRNA) delivery into hard-to-transfect macrophages. This innovation advances the field of non-viral gene delivery, offering improved biocompatibility and mRNA protection compared to conventional methods.